Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,179,916 papers from all fields of science
Search
Sign In
Create Free Account
GW 280430A
Known as:
GW-280430A
, GW280430A
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
gantacurium
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2005
Review
2005
GW280430A: pharmacodynamics and potential adverse effects.
C. Lien
,
M. Belmont
,
P. Heerdt
Anesthesiology
2005
Corpus ID: 41400822
To the Editor:—We appreciate the three articles in the April 2004 issue of ANESTHESIOLOGY regarding GW280430A. Although…
Expand
Highly Cited
2004
Highly Cited
2004
Clinical Pharmacology of GW280430A in Humans
M. Belmont
,
C. Lien
,
+4 authors
J. Savarese
Anesthesiology
2004
Corpus ID: 21857500
BackgroundAn ultrashort-acting nondepolarizing neuromuscular blocking agent that could be an alternative to succinylcholine has…
Expand
2004
2004
Preclinical Pharmacology of GW280430A (AV430A) in the Rhesus Monkey and in the Cat: A Comparison with Mivacurium
J. Savarese
,
M. Belmont
,
+11 authors
W. Wastila
Anesthesiology
2004
Corpus ID: 1006654
BackgroundNo replacement for succinylcholine is yet available. GW280430A (AV430A) is a representative of a new class of…
Expand
2004
2004
Did experimenter bias conceal the efficacy of spinal opioids in previous studies with the spinal nerve ligation model of neuropathic pain?
J. Eisenach
,
M. D. Lindner
Anesthesiology
2004
Corpus ID: 456896
THE introduction of succinylcholine into clinical practice in 1951 was a seminal development in the history of anesthesia. Since…
Expand
2004
2004
Cardiopulmonary Effects of the Novel Neuromuscular Blocking Drug GW280430A (AV430A) in Dogs
P. Heerdt
,
Richard Kang
,
Andrew H S The
,
M. Hashim
,
R. Mook
,
J. Savarese
Anesthesiology
2004
Corpus ID: 28463992
BackgroundThis investigation determined the cardiopulmonary side effects of a novel nondepolarizing neuromuscular blocking drug…
Expand
2004
2004
The continuing search for a succinylcholine replacement.
J. Caldwell
Anesthesiology
2004
Corpus ID: 42600598
THE introduction of succinylcholine into clinical practice in 1951 was a seminal development in the history of anesthesia. Since…
Expand
2002
2002
Preformulation Studies for an Ultrashort-Acting Neuromuscular Blocking Agent GW280430A. I. Buffer and Cosolvent Effects on the Solution Stability
H. Zhu
,
K. Meserve
,
A. Floyd
Drug Development and Industrial Pharmacy
2002
Corpus ID: 10837747
ABSTRACT GW280430A is an ultrashort-acting neuromuscular blocking agent targeted at muscle relaxation to facilitate surgical…
Expand
2002
2002
The pharmacology of GW280430A: A new nondepolarizing neuromuscular blocking agent
C. Lien
2002
Corpus ID: 72934824
2002
2002
Solid state characterization of an neuromuscular blocking agent--GW280430A.
H. Zhu
,
M. Sacchetti
International journal of pharmaceutics
2002
Corpus ID: 5566
Review
2001
Review
2001
The new neuromuscular blocking agents: do they offer any advantages?
E. Moore
,
J. Hunter
British Journal of Anaesthesia
2001
Corpus ID: 18375100
The pharmacodynamics and pharmacokinetics of the two most recent aminosteroid neuromuscular blocking drugs to become available…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE